Mental Health Clinics in Port Clinton, OH Accepting Medicare
7 Mental Health Clinics found. Showing 1 - 7
 Melinda Koskela, Llc Community/Behavioral Health Agency Medicare: Not Enrolled in Medicare Practice Location: 318 Madison St, Port Clinton, OH 43452 Phone: 419-635-5695 Fax: 419-734-2123 |
Grow Or Go Therapy Solutions, Llc Counselor - Addiction (Substance Use Disorder) Medicare: Not Enrolled in Medicare Practice Location: 1854 E Perry St Ste 900, Port Clinton, OH 43452 Phone: 419-359-5110 Fax: 419-359-5114 |
Bayshore Counseling Services Community/Behavioral Health Agency Medicare: Not Enrolled in Medicare Practice Location: 201 Madison St Fl 3, Port Clinton, OH 43452 Phone: 149-734-5534 Fax: 149-734-5536 |
The Giving Tree, Inc. Counselor - Addiction (Substance Use Disorder) Medicare: Not Enrolled in Medicare Practice Location: 335 Buckeye Blvd, Port Clinton, OH 43452 Phone: 419-734-2942 Fax: 419-734-4922 |
Advanced Neurologic Associates, Inc Psychiatry & Neurology - Neurology Medicare: Not Enrolled in Medicare Practice Location: 1250 Fulton St, Port Clinton, OH 43452 Phone: 419-483-2403 Fax: 419-484-1203 |
Giving Tree Inc. Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 335 Buckeye Blvd, Port Clinton, OH 43452 Phone: 419-734-2942 Fax: 419-734-4922 |
Psychological Transitions, Inc Psychologist - Clinical Medicare: Medicare Enrolled Practice Location: 3850 E Harbor Light Landing Dr, Port Clinton, OH 43452 Phone: 419-734-3333 Fax: 877-734-2030 |
News Archive
N30 Pharmaceuticals presents preclinical data of GSNORi at European Cystic Fibrosis Society meeting
N30 Pharmaceuticals, Inc., a clinical stage, biopharmaceutical company focused on the development of therapies for cystic fibrosis, announced today the presentation of key preclinical data for its novel inhibitors of S-nitrosoglutathione reductase.
Molecular models advance the fight against malaria
Research from Dartmouth Medical School, demonstrating how malaria parasites form mutations that make them stubbornly resistant to drug therapy, may hold the key to a new treatments for a disease that afflicts more than half a billion people worldwide.
Children with hypertension more likely to have learning disabilities, ADHD
Children who have hypertension are much more likely to have learning disabilities than children with normal blood pressure, according to a new University of Rochester Medical Center (URMC) study published this week in the journal, Pediatrics. In fact, when variables such as socio-economic levels are evened out, children with hypertension were four times more likely to have cognitive problems.
Researchers shed new light on the function of huntingtin, the protein whose mutation underlies Huntington's disease
CNRS and Inserm research scientists at the Institut Curie have shed new light on the function of huntingtin, the protein whose mutation underlies Huntington's disease.
FDA grants Breakthrough Therapy designation to GSK's Promacta/Revolade for treatment of cytopenias
Ligand Pharmaceuticals Incorporated today announced that the U.S. Food and Drug Administration has granted its partner GlaxoSmithKline plc Breakthrough Therapy designation for Promacta/Revolade (eltrombopag) for the treatment of cytopenias in patients with severe aplastic anemia (SAA) who have had insufficient response to immunosuppressive therapy.
› Verified 3 days ago